BOSTON— Avania, a global clinical research organization specializing in MedTech, has announced two senior executive appointments aimed at enhancing its global business strategy and client engagement capabilities.
Jasmine Saba has been named Senior Vice President of Strategic Relationships, while Josh Blacker joins the company as Senior Vice President of Global Business Development.
The appointments come as Avania continues to expand its footprint across North America, Europe, and Asia-Pacific, supporting medical technology companies from concept to commercialization.
In her new role, Saba will focus on building and managing strategic partnerships with major multinational MedTech companies. Leveraging her background in R&D, clinical operations, and sales, she will develop scalable collaboration models to help clients integrate Avania’s services into their operational pipelines.
Blacker, a veteran of the life sciences industry, will lead Avania’s global business development efforts. He brings extensive experience from leadership roles at Chiltern, Worldwide Clinical Trials, and Evestia Clinical, where he most recently served as Executive Vice President of Commercial. At Avania, Blacker will oversee business development teams across all regions, targeting MedTech clients at every stage of development.
“We recognize the MedTech industry is constantly evolving, and we remain committed to delivering flexible, solution-driven partnerships,” said Jason Monteleone, President and CEO of Avania. “I’m thrilled to welcome Josh Blacker and equally excited to announce Jasmine Saba in her new role. These strategic moves will further strengthen our ability to meet our clients’ growing and dynamic needs.”
The leadership additions underscore Avania’s focus on innovation and partnership as it continues to expand its global presence in the medical technology sector.
